Sopharma AD-Sofia (XBUL:SFA) EPS (Basic) : лв0.54 (TTM As of Jun. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Sopharma AD-Sofia EPS (Basic)?

Sopharma AD-Sofia's basic earnings per share (Basic EPS) for the three months ended in Jun. 2024 was лв0.10. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Jun. 2024 was лв0.54.

Sopharma AD-Sofia's EPS (Diluted) for the three months ended in Jun. 2024 was лв0.10. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was лв0.51.

Sopharma AD-Sofia's EPS without NRI for the three months ended in Jun. 2024 was лв0.08. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Jun. 2024 was 0.47.

During the past 12 months, Sopharma AD-Sofia's average EPS without NRIGrowth Rate was -38.10% per year. During the past 3 years, the average EPS without NRI Growth Rate was 31.20% per year. During the past 5 years, the average EPS without NRI Growth Rate was 14.10% per year. During the past 10 years, the average EPS without NRI Growth Rate was 11.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Sopharma AD-Sofia's highest 3-Year average EPS without NRI Growth Rate was 41.50% per year. The lowest was -18.60% per year. And the median was 4.25% per year.

Sopharma AD-Sofia EPS (Basic) Historical Data

The historical data trend for Sopharma AD-Sofia's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sopharma AD-Sofia EPS (Basic) Chart

Sopharma AD-Sofia Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EPS (Basic)

Get a 7-Day Free Trial

0.69

0.24

0.71

0.59

0.73

Sopharma AD-Sofia Quarterly Data
	Jun19	Sep19	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
EPS (Basic)	Get a 7-Day Free Trial															0.25	0.12	0.09	0.23	0.10

Sopharma AD-Sofia EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Sopharma AD-Sofia's Basic EPS for the fiscal year that ended in Dec. 2023 is calculated as

Basic EPS (A: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(95.977	-	0)	/	130.696
	=	0.73

Sopharma AD-Sofia's Basic EPS for the quarter that ended in Jun. 2024 is calculated as

Basic EPS (Q: Jun. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(16.143	-	0)	/	196.398
	=	0.08

EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was лв0.54

Sopharma AD-Sofia (XBUL:SFA) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Sopharma AD-Sofia EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Sopharma AD-Sofia's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Sopharma AD-Sofia Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Sopharma AD-Sofia (XBUL:SFA) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

SPH:Poland

Address

5 Lachezar Stanchev Street, Sopharma Business Towers, Building A, Floor 11, Sofia, BGR, 1756

Website

https://www.sopharmagroup.com

Sopharma AD-Sofia is a company engaged in the production of pharmaceutical products. Its principal activities include the production and trade of medicinal substances and finished drug forms; and research and development as well as engineering and implementation activities in the field of medicinal products. It is also focused on the distribution of pharmaceuticals like medical supplies, sanitary materials, vitamins, food supplements, and cosmetics. The company's segments are the Production of pharmaceutical products; Distribution of pharmaceutical products; and Others. It generates the majority of its revenue from the Distribution of pharmaceutical products.

Sopharma AD-Sofia Headlines

No Headlines